Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23585522 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care
Condition: Myelodysplastic Syndromes
Interventions: Drug: Azacitidine;   Other: Physician Choice

Indicates status has not been verified in more than two years